예고한 바와 같이 KOL 미팅을 개최한다. - 9월 27일, 0800 ~ 0900AM(EDT)
- 중요 업데이트 : 키트루다콤보(Versatile-002) / CPI Naive & CPI 불응성 추가 데이터 공개
▶ CPI 불응성 데이터를 확인 할 수 있다. 개인적으론 이게 가장 중요 포인트라 본다.. 삼중콤보 3상 임상준비에 있어 중요한 포인트이다.
PDS Biotech - PDS Biotech to Host Key Opinion Leader Roundtable Addressing Current and Future Treatments for Recurrent/Metastatic HPV-Positive HNSCC and the Potential Application of PDS0101 on September 27, 2023
DEVELOPING POWERFUL, SAFE, VERSATILE IMMUNOTHERAPIES
PDS Biotech is committed to developing novel and effective therapies based on the Versamune® platform to save and improve the lives of cancer patients worldwide. We are also committed to developing safer and more powerful infectious disease vaccines to pr
pdsbiotech.com
일정 변경 (스케줄 재조정)
- 10월 3일, 0800 ~ 0900AM(EDT)
https://pdsbiotech.com/index.php/investors/news-center/press-releases/press-releases1/125-2023-news/875-iotechescheduleseypinioneaderoundtableddre20230925
DEVELOPING POWERFUL, SAFE, VERSATILE IMMUNOTHERAPIES
PDS Biotech is committed to developing novel and effective therapies based on the Versamune® platform to save and improve the lives of cancer patients worldwide. We are also committed to developing safer and more powerful infectious disease vaccines to pr
pdsbiotech.com
스케줄만 조정 되었을뿐 다른 특이사항은 없다.
'PDS Biotech > 2023' 카테고리의 다른 글
| ASTRO 23 - PDS0101 + 케모(방사선)콤보 (0) | 2023.10.02 |
|---|---|
| SITC 23 - PDS0301(NHS-IL12, M9241) / 포스터 세션 (0) | 2023.09.29 |
| 무적(?)이라 생각했던 키트루다 or 콤보.. (0) | 2023.09.24 |
| PDS0202 전임상 데이터 발표 - ESWI23 (0) | 2023.09.21 |
| ESWI 23 - PDS0202 전임상 데이터 발표 (0) | 2023.09.06 |
